Aureum Diagnostics develops low-cost electrochemical biosensing platforms for point-of-care medical diagnostics, utilizing a handheld instrument and single-use test strips to deliver rapid and accurate test results. This technology provides timely diagnosis in clinical settings, enhancing patient outcomes and optimizing healthcare workflows.
Funding
Funding not disclosed
Founders
Product
Problem
Current point-of-care diagnostic methods often lack the sensitivity, speed, and cost-effectiveness required for widespread use, particularly in resource-limited settings. Traditional lab-based diagnostics can be slow and expensive, hindering timely medical intervention. Existing point-of-care solutions may compromise on accuracy or ease of use.
Solution
Aureum Diagnostics is developing electrochemical biosensing platforms that combine high performance with low cost for point-of-care medical diagnostics and biosafety testing. Their system comprises a handheld, connected instrument and single-use disposable test strips, enabling rapid and accurate "sample-to-result" analysis. The electrochemical technology allows for sensitive and cost-effective measurement of metabolites, proteins, and nucleic acid targets. The platform is designed to meet core user needs, including high sensitivity, ease of use, rapid test times, cost-effectiveness, and a reduced environmental footprint.
Target Audience
The primary target audience includes healthcare providers, medical facilities, and biosafety testing organizations seeking rapid, accurate, and cost-effective point-of-care diagnostic solutions.
Features
- Handheld, connected instrument for on-site analysis
- Single-use disposable test strips for ease of use and reduced contamination risk
- Electrochemical biosensing technology for rapid and sensitive detection
- Capability to measure metabolites, proteins, and nucleic acid targets
- Low-cost design for accessibility in diverse healthcare settings
- Eco-friendly footprint through sustainable design principles